Navigation Links
HHS Issues First Department-Wide Report on Personalized Health Care
Date:9/19/2007

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- Health and Human Services Secretary Mike Leavitt today released the first department-wide report on the goal of personalized health care and said work in biomedical science, health information technology and health care delivery should be aligned to produce "the right treatment, at the right time" for each individual patient.

The report, Personalized Health Care: Opportunities, Pathways, Resources, presents a long-range plan for achieving much more individualized treatment for patients, especially by using genetic information and health information technology (IT). Together, health information and IT can give clinicians better information about each patient and more support in choosing "best care" options for treatment.

"Health care professionals have always aimed at making medical care as individualized as possible. But in truth, our ability to deliver the right care for each person has been limited," Secretary Leavitt writes in a foreword to the report.

The report was produced as part of Secretary Leavitt's priority initiative on personalized health care. It describes how the exploding knowledge of the human genome will increase the capacity to predict, detect, preempt and treat disease, by enabling physicians to "look beneath" visible symptoms and see signs and causes of disease at the molecular level. The report also describes how health IT can make patient information accessible securely, while maintaining confidentially, as well as how it can support high quality care. Health IT can even help clinicians and researchers ascertain which treatments are most effective and for whom, by using broad-scale data derived from day-to-day medical practice.

The report includes descriptions of the opportunities presented by science and technology. It also outlines pathways where work is needed. The report presents the first inventory of some 50 related programs underway throughout HHS.

Secretary Leavitt said the combination of genomic medicine, health IT, and better use of medical evidence will make possible much more effective health care -- such as learning which medicines, at what dosages, work best for which patients.

"Personalized health care means knowing what works, knowing why it works, knowing who it works for, and applying that knowledge for patients," he writes. "These goals may sound elementary, but a generation of effort lies ahead of us in achieving them."

Secretary Leavitt emphasized that personalized medicine, especially the use of genomic data, will require further attention to using information correctly, including protecting the privacy of identifiable personal health information and protection against misuse of that information. The Secretary also noted that the Bush Administration, since 2001, has supported enactment of federal law to protect against misuse of genomic information in employment and health insurance.

Some highlights of related activities in HHS include:

-- Genome-wide Association Studies, sponsored especially by the

National Institutes of Health (NIH), to identify genetic elements

in disease. New findings from these studies are now being reported

at a rapidly accelerating pace.

-- Efforts by the Centers for Disease Control and Prevention (CDC) to

describe population-wide genomic characteristics and to help lay the

groundwork for using genomic elements in health care.

-- Programs under the National Cancer Institute (NCI) to improve

understanding of the causes of cancer and to improve treatment through

scientific advancement as well as new programs for sharing "best

treatment" information.

-- HHS-supported efforts in health IT to develop technical standards and

provide for secure exchange of medical data, aimed at supporting the

President's goal of electronic health records for most Americans by

2014.

-- New guidance and planning by the Food and Drug Administration (FDA) to

lay the groundwork for rapid development of useful new products, and

for integrating genomic information into drug prescribing and disease

diagnosis.

-- Efforts by NIH, CDC, the Agency for Healthcare Research and Quality

(AHRQ), the Health Resources and Services Administration (HRSA) and

the Indian Health Service (IHS) to accelerate the translation of

scientific discoveries and "best practice" information into clinical

practice.

The report is available on the HHS Web site at http://www.hhs.gov/myhealthcare/.

Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.


'/>"/>
SOURCE U.S. Department of Health and Human Services
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Stabilizing RNA in Fresh and Frozen Tissues for RNA Isolation
2. Genomic DNA Preparation from RNAlater Preserved Tissues
3. Preparation of PCR Quality Template DNA from a Wide Range of Tissues Using InstaGene Matrix
4. Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System
5. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
6. Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data
7. Evaluation of RNA isolated from human tissues: quality control for surgical and postmortem samples
8. Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA)
9. Inline intellectual property raises legal issues
10. SC Johnson issues trademark warning over web offer
11. Company issues warning on outsourced software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... , March 22, 2016 ... research report "Electronic Sensors Market for Consumer Industry by ... & Others), Application (Communication & IT, Entertainment, ... - Global Forecast to 2022", published by ... is expected to reach USD 26.76 Billion ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
Breaking Biology News(10 mins):